(By Nick Moran for Becker’s Hospital Review)
CMS is proposing a new rule that aims to cut prescription drug costs, increase contract vetting and improve health equity, according to a Jan. 6 news release.
The proposed changes primarily target Medicare Advantage and Part D plans. CMS also noted that the proposed changes come with “modest costs” that should not affect bidding, premiums or benefits. Continue reading here…
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org